Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT03882970

Public ClinicalTrials.gov record NCT03882970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes

Study identification

NCT ID
NCT03882970
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,444 participants

Conditions and interventions

Interventions

  • Tirzepatide Drug
  • Insulin Degludec Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2019
Primary completion
Dec 10, 2020
Completion
Jan 3, 2021
Last update posted
Jan 18, 2022

2019 – 2021

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arkansas Clinical Research Little Rock Arkansas 72205
Valley Research Fresno California 93720
National Research Institute Huntington Park California 90255
National Research Institute Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Valley Clinical Trials, Inc. Northridge California 91325
National Research Institute Panorama City California 91402
Encompass Clinical Research Spring Valley California 91978
University Clinical Investigators, Inc. Tustin California 92780
Chase Medical Research, LLC Waterbury Connecticut 06708
Indago Research & Health Center, Inc. Hialeah Florida 33012
East Coast Clinical Research Jacksonville Florida 32204
East Coast Institute For Research Jacksonville Florida 32216
Bayside Clinical Research, LLC New Port Richey Florida 34655
East Coast Institute For Research Macon Georgia 31210
Sky Clinical Research Network Union City Georgia 30291
Elite Clinical Trials LLLP Blackfoot Idaho 83221
Humphreys Diabetes Center Boise Idaho 83702
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Springfield Diabetes & Endocrine Center Springfield Illinois 62711
Crescent City Clinical Research Metairie Louisiana 70006
Endocrine and Metabolic Consultants Rockville Maryland 20852
Troy Internal Medicine, PC Troy Michigan 48098
International Diabetes Center Minneapolis Minnesota 55416
Clinical Research Professionals Chesterfield Missouri 63005
Palm Research Center Las Vegas Nevada 89128
Palm Research Center Las Vegas Nevada 89148
Aventiv Research Columbus Ohio 43213
The Corvallis Clinic P.C. Corvallis Oregon 97330
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009
Detweiler Family Medicine Lansdale Pennsylvania 19446
Office of Dr. Osvaldo Brusco Corpus Christi Texas 78414
Consano Clinical Research Shavano Park Texas 78231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03882970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03882970 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →